NYSE:IQV - New York Stock Exchange, Inc. - US46266C1053 - Common Stock - Currency: USD
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Friday.
Get insights into the S&P500 index performance on Wednesday. Explore the top gainers and losers within the S&P500 index in today's session.
Stay informed about the performance of the S&P500 index in the middle of the day on Wednesday. Uncover the top gainers and losers in today's session for valuable insights.
The headline numbers for IQVIA (IQV) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
IQV's top line in the first quarter of 2025 benefits from the Research and Development, and Technology and Analytics segments.
As we await the opening of the US market on Tuesday, let's delve into the pre-market session and discover the S&P500 top gainers and losers shaping the early market sentiment.
Clinical research company IQVIA (NYSE: IQV) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 2.5% year on year to $3.83 billion. The company’s full-year revenue guidance of $16.2 billion at the midpoint came in 2.1% above analysts’ estimates. Its non-GAAP profit of $2.70 per share was 2.6% above analysts’ consensus estimates.
IQVIA (IQV) delivered earnings and revenue surprises of 2.66% and 1.55%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: NSPR
Clinical research company IQVIA (NYSE: IQV) will be reporting earnings tomorrow before the bell. Here’s what to expect.
Growth across the R&DS and TAS segments is anticipated to have boosted IQV's top line in the first quarter of 2025.
Evaluate the expected performance of IQVIA (IQV) for the quarter ended March 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Medical stocks are usually considered defensive. But have they been too hammered by regulatory changes to hold up this year?
RxSight (RXST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Mentions: RXST
IQVIA (IQV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Mentions: TFX
The US market session of Tuesday has yet to be opened, let's have a look at the top S&P500 gainers and losers in the pre-market session today.
Stay updated with the S&P500 stocks that are on the move in today's pre-market session.
We recently published a list of 10 Best Stocks to Buy According to Billionaire Steve Cohen. In this article, we are going to take a look at where The Coca-Cola Company (NYSE:KO) stands against other best stocks to buy according to billionaire Steve Cohen. Steve Cohen, a prominent figure in the world of hedge funds, […]
Darling Ingredients (DAR) issued the following statement regarding tariffs. “Darling Ingredients is a resilient global business, operating 260 facilities across five continents. Our scale, geographic diversity and integrated supply chain enable us to adapt quickly to changing market dynamics and continue meeting customer needs around the world. The vast majority of the ingredients we produce in the U.S. are utilized domestically, with minimal exposure to exports impacted by current tariffs, incl
Performance Shipping (PSHG) announced that, through a separate wholly-owned subsidiary, it has entered into a forward sale and exclusivity agreement with an unaffiliated third party. This agreement grants the Buyer exclusive rights to submit a bid for the conversion of the Company’s Aframax tanker, M/T P. Sophia, in an auction for the provision of a Floating Production Storage and Offloading vessel for charter to a national oil company. If the Buyer is awarded the Offshore Project by the expirat
We recently published a list of 15 Stocks with Buy Ratings that Hedge Funds Love. In this article, we are going to take a look at where U.S. Foods Holding Corp. (NYSE:USFD) stands against other stocks with buy ratings that hedge funds love. The U.S. stock market has been in chaos ever since President Trump […]
We recently published a list of 15 Stocks with Buy Ratings that Hedge Funds Love. In this article, we are going to take a look at where IQVIA Holdings Inc. (NYSE:IQV) stands against other stocks with buy ratings that hedge funds love. The U.S. stock market has been in chaos ever since President Trump announced […]